FERMT2 and melanoma: All BRAF‐mutant melanoma cell lines showed reduced survival upon targeting of BRAF. The screen identified melanoma fitness genes having an effect size similar to BRAF, including CHMP4B, FERMT2 and DUSP4 supporting their potential as therapeutic targets (Figure 2).